Neurogene Inc.
NGNE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$75,144 | -$36,317 | -$55,189 | -$50,517 |
| Dep. & Amort. | $3,247 | $3,297 | $3,200 | $947 |
| Deferred Tax | $0 | -$105 | $0 | $0 |
| Stock-Based Comp. | $8,320 | $1,418 | $1,252 | $896 |
| Change in WC | -$5,961 | -$4,023 | -$2,695 | $1,595 |
| Other Non-Cash | -$1,065 | -$15,692 | $608 | $679 |
| Operating Cash Flow | -$70,603 | -$51,422 | -$52,824 | -$46,400 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$808 | -$321 | -$2,230 | -$18,369 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$198,453 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $74,000 | $5,000 | $0 | $0 |
| Other Inv. Act. | $0 | $20,958 | $0 | $0 |
| Investing Cash Flow | -$125,261 | $25,637 | -$2,230 | -$18,369 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$52 | -$29 | -$1 | $0 |
| Stock Issued | $189,589 | $92,343 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$5,466 | $168 | $66,532 | $51,063 |
| Financing Cash Flow | $184,071 | $92,482 | $66,531 | $51,063 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$11,793 | $66,697 | $11,477 | -$13,706 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $148,718 | $82,021 | $70,544 | $84,250 |
| End Cash | $136,925 | $148,718 | $82,021 | $70,544 |
| Free Cash Flow | -$71,411 | -$51,743 | -$55,054 | -$64,769 |